[{"Assets_0_Q3_USD":70270000.0,"CommonStockSharesOutstanding_0_Q3_shares":40524335.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-35579000.0,"NetIncomeLoss_1_Q3_USD":-15010000.0,"NetIncomeLoss_3_Q3_USD":-42579000.0,"StockholdersEquity_0_Q3_USD":45517000.0,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]